Scholars@Duke publication: P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?

Journal cover image

P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?

Publication , Conference

MAHAFFEY, K

Published in: European Heart Journal

March 2003

Published version (DOI) Publisher Link

Duke Scholars

Author Christopher Bull Granger Medicine, Cardiology

Published In

European Heart Journal

DOI

10.1016/s0195-668x(03)94765-8

ISSN

0195-668X

Publication Date

March 2003

Volume

24

Issue

5

Start / End Page

301 / 301

Publisher

Elsevier BV

Related Subject Headings

Cardiovascular System & Hematology
3202 Clinical sciences
3201 Cardiovascular medicine and haematology
1103 Clinical Sciences
1102 Cardiorespiratory Medicine and Haematology

Citation

APA

Chicago

ICMJE

MLA

NLM

MAHAFFEY, K. (2003). P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention? In European Heart Journal (Vol. 24, pp. 301–301). Elsevier BV. https://doi.org/10.1016/s0195-668x(03)94765-8

MAHAFFEY, K. “P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?” In European Heart Journal, 24:301–301. Elsevier BV, 2003. https://doi.org/10.1016/s0195-668x(03)94765-8.

MAHAFFEY K. P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention? In: European Heart Journal. Elsevier BV; 2003. p. 301–301.

MAHAFFEY, K. “P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?” European Heart Journal, vol. 24, no. 5, Elsevier BV, 2003, pp. 301–301. Crossref, doi:10.1016/s0195-668x(03)94765-8.

MAHAFFEY K. P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention? European Heart Journal. Elsevier BV; 2003. p. 301–301.

Journal cover image

Published In

European Heart Journal

DOI

10.1016/s0195-668x(03)94765-8

ISSN

0195-668X

Publication Date

March 2003

Volume

24

Issue

5

Start / End Page

301 / 301

Publisher

Elsevier BV

Related Subject Headings

Cardiovascular System & Hematology
3202 Clinical sciences
3201 Cardiovascular medicine and haematology
1103 Clinical Sciences
1102 Cardiorespiratory Medicine and Haematology